Semaglutide: The Newest Once-Weekly GLP-1 RA for Type 2 Diabetes

Tuchscherer, RM; Thompson, AM; Trujillo, JM

Thompson, AM (reprint author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Clin Pharm, Mail Stop C238,12850 E Montview Blvd, Aurora, CO 80045 USA.

ANNALS OF PHARMACOTHERAPY, 2018; 52 (12): 1224

Abstract

Objective: To review efficacy and safety of the glucagon-like peptide-1 receptor agonist (GLP-1 RA) semaglutide for type 2 diabetes (T2D). Data Source......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索